Archived explainer. For the current picture see today's CRL page.
Why Is CHARLES RIV LABORATO (CRL) Stock Up Today?
By the Top Tier Newswire AI Desk · October 6, 2026 at 9:44 AM ET · reviewed against 3 wire stories
CHARLES RIV LABORATO (CRL) is up +7.06% in the latest session. Our newswire has captured 3 stories on CRL across 3 sources in the last 36 hours, with AI sentiment reading bullish (avg 62/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Charles River Laboratories International (CRL) shares rose 7.06% to $332.72 in morning trading on Monday following the announcement of a new digital laboratory execution platform in partnership with Autolomous. The stock opened with a 1.0% gap up and surged to a session high of $332.80 shortly after the market opened. The move reflects investor optimism around the company’s strategic collaboration to enhance digital capabilities in laboratory execution.
What Happened
CRL and Autolomous launched Apollo Orchestrate, a digital solution integrated into Charles River’s operations to streamline laboratory execution. The product leverages Autolomate technology to digitize processes, aiming to improve efficiency and reduce manual workflows. The partnership was announced in multiple reports over the past 36 hours, with details highlighting the integration of digital tools to modernize lab execution systems. This collaboration is positioned as a transformative step in the company’s digital strategy.
What The Data Shows
The stock opened at $313.79 and climbed to a high of $332.80, a level that surpasses its 52-week high of $312.26. Volume in the session reached 0.2 million shares, matching the 3-month average. Over the past eight sessions, the stock has risen 3.2% from $294.44 to $303.96. The stock also hit a fresh 52-week high on October 6. Recent insider transactions show mixed activity, with $3,000 in buys and $25.7 million in sells reported in the last 90 days.
What To Watch
The stock is set to continue its momentum in the near term. Analysts from UBS, Jefferies, and Deutsche Bank have maintained or raised price targets recently, with UBS setting a $357 target. Investors may monitor the stock’s performance ahead of any potential earnings release or further strategic updates.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
CRL · today's session (5-min) · -1.33% vs prior close · updated 3:08 PM ETAI sentiment, last 36h · averaged over 3 stories · 62/100 bullish
The headlines behind the move
Story flow · 3 stories on the wire, last 36h · hover or tap a dot for the headline
7h agoSeeking AlphaBULLISH 63Product/PR
Charles River Labs and Autolomous launch Apollo Orchestrate for digital lab execution
Charles River Laboratories International (CRL) and digital solution provider Autolomous have launched Apollo Orchestrate, a digital laboratory execution capability integrated into Charles River
7h agoThe FlyBULLISH 56Product/PR
Charles River, Autolomous announce launch of Apollo Orchestrate
7h agoStockTitanBULLISH 66Product/PR
Charles River and Autolomous Partner to Transform Laboratory Execution Systems
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →